Transendocardial delivery of extracellular myocardial markers by using combination x-ray/MR fluoroscopic guidance: Feasibility study in dogs

Radiology

Volumn 231, Issue 3, 2004, Pages 689-696

  Saeed, Maythem ^a   Lee, Randall ^a   Martin, Alastair ^b   Weber, Oliver ^a   Krombach, Gabriele A ^a   Schalla, Simon ^a   Lee, Michael ^c   Saloner, David ^a   Higgins, Charles B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PHILIPS HEALTHCARE   (United States)

^c Bioheart Inc   (United States)

Author keywords

Animals; Catheters and catheterization; Experimental study; Guidance; Heart, interventional procedures; Magnetic resonance (MR)

Indexed keywords

CONTRAST MEDIUM; EVANS BLUE; GADODIAMIDE; GADOLINIUM; IOHEXOL; MARKER;

ANIMAL EXPERIMENT; ARTERY CATHETER; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOG; DOUBLE LUMEN TUBE; ELECTROCARDIOGRAPHY; FLUOROSCOPY; GUIDE WIRE; HEART CATHETERIZATION; HEART RATE; IMAGE ANALYSIS; IMAGE ENHANCEMENT; INJECTION; INTERVENTIONAL RADIOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN SATURATION; PRIORITY JOURNAL; STEADY STATE; TECHNIQUE; THREE DIMENSIONAL IMAGING; VASCULAR ACCESS; X RAY;

ANIMALS; COLORING AGENTS; CONTRAST MEDIA; DOGS; DRUG DELIVERY SYSTEMS; EVANS BLUE; FEASIBILITY STUDIES; FLUOROSCOPY; GADOLINIUM DTPA; HEART CATHETERIZATION; IMAGE PROCESSING, COMPUTER-ASSISTED; IOHEXOL; MAGNETIC RESONANCE IMAGING; MYOCARDIUM;

EID: 2442709106     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2313030683     Document Type: Article

References (23)

1. Losordo DW, Vale PR, Symes JF, et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998; 98:2800-2804.
2. Symes JF, Losordo DW, Vale PR, et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 1999; 68: 830-836.
3. Rosengart TK, Lee LY, Patel SR, et al. Angiogenesis gene therapy: phase 1 assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 1999; 100:468-474.
4. 165 as sole therapy in patients with refractory coronary artery disease: 12-month follow-up-angiogenic gene therapy. J Intern Med 2001; 250:373-381.
5. Lazarous DF, Scheinowitz M, Shou M, et al. Effect of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 1995; 91:145-153.
6. Giordano FJ, Ping P, Mckirnan D, et al. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat Med 1996; 2:534-539.
7. Simons M. Phase II, multicenter, double-blind, placebo-controlled, dose-finding study for safety, pharmakocinetics, and efficacy of recombinant fibroblast growth factor (rFGF-2) in subjects with coronary artery disease (CAD): FGF-2 Initiating Revascularization Support Trial (FIRST). J Am Coll Cardiol 2000; 36:310-325.
8. Laham RJ, Rezaee M, Post M, et al. Intracoronary and intravenous administration of basic fibroblast growth factor: myocardial and tissue distribution. Drug Metab Dispos 1999; 27:821-826.
9. Inoue M, Itoh H, Ueda M, et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998; 98:2108-2116.
10. Wolf T, Gepstein L, Dror U, et al. Detailed endocardial mapping accurately predicts the transmural extent of myocardial infarction. J Am Coll Cardiol 2001; 37: 1590-1597.
11. Wolf T, Gepstein L, Hayam G, et al. Three-dimensional endocardial impedance mapping: a new approach for myocardial infarction assessment. Am J Physiol Heart Circ Physiol 2001; 280:H179-H188.
12. Perin EC, Silva GV, Sarmento-Leite R, et al. Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: validation by delayed-enhancement magnetic resonance imaging. Circulation 2002; 106:957-961.
13. Lederman RJ, Guttman MA, Peters DC, et al. Catheter-based endomyocardial injection with real-time magnetic resonance imaging. Circulation 2002; 105:1282-1284.
14. Yang X, Atalar E, Li D, et al. Magnetic resonance imaging permits in vivo monitoring of catheter-based vascular gene delivery. Circulation 2001; 104:1588-1590.
15. Kraitchman DL, Heldman AW, Atalar E, et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003; 107:2290-2293.
16. Kuehne T, Saeed M, Higgins CB, et al. Endovascular stents in pulmonary valve and artery in swine: feasibility study of MR imaging-guided deployment and postinterventional assessment. Radiology 2003; 226:475-481.
17. National Institutes of Health. NIH image. Available at: http://rsb.info.nih.gov/nih-image/. Accessed October 30, 2002.
18. Saeed M, Wendland MF, Szolar D, et al. Quantification of the extent of area at risk with fast contrast-enhanced magnetic resonance imaging in experimental coronary artery stenosis. Am Heart J 1996; 132:921-923.
19. Saeed M, Higgins CB, Geschwind JF, et al. T1-relaxation kinetics of extracellular, intracellular and intravascular MR contrast agents in normal and acutely reperfused infarcted myocardium using echoplanar MR imaging. Eur Radiol 2000; 10:310-318.
20. Kitagawa K, Sakuma H, Hirano T, et al. Acute myocardial infarction: myocardial viability assessment in patients early thereafter-comparison of contrast-enhanced MR imaging with resting (201)T1 SPECT. Radiology 2003; 226:138-144.
21. Saeed M, Lund G, Wendland MF, et al. Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction using necrosis specific and extracellular nonspecific contrast media. Circulation 2001; 103:871-876.
22. Vale PR, Losordo DW, Milliken CE, et al. Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation 2000; 102:965-974.
23. Hill JM, Dick AJ, Raman VK, et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 2003; 108:1009-1014.